Surgery study for advanced ovarian cancer after chemotherapy
Part of Cancer, Hormones & metabolism, Women’s health & pregnancy clinical trials.
This study looks at how well a minimally invasive surgery (laparoscopic debulking) can remove tumor in people with advanced epithelial ovarian cancer. It may help doctors compare whether this approach is safe and effective for patients who need either upfront surgery or surgery after chemotherapy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Have advanced epithelial ovarian cancer (stage II to IV), including cancers of the fallopian tubes or the lining of the abdomen
- Be a candidate for primary debulking surgery (upfront) or interval debulking surgery (after chemotherapy)
- Be willing and able to sign consent to join the study
- Be age 18 or older and female
- Your overall health must be strong enough for major surgery (Karnofsky score at least 70)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether using a small-scope (minimally invasive) surgery instead of a large incision can safely remove remaining ovarian cancer after chemotherapy. It may mean a faster recovery and fewer complications.
This trial checks if adjusting the timing of surgery (interval debulking surgery) after chemotherapy can improve outcomes for people with advanced ovarian cancer. It's for those who cannot have surgery right away and will receive chemotherapy first.
This trial checks whether having surgery to remove as much tumor as possible, followed by ongoing targeted treatment, helps people with advanced ovarian (and related) cancers live longer and/or control cancer better. It specifically uses tumor-testing results to match patients and then continues treatment after surgery.
This study looks at whether the timing of surgery after chemotherapy can be personalized for advanced ovarian cancer. It uses a blood test (CA125) to help decide the best time for surgery, aiming to improve outcomes.
This trial looks at whether a specific treatment pathway that may include surgery helps people with advanced ovarian (or related) cancer. It mainly involves planning and undergoing a complex pelvic surgery, sometimes after chemotherapy, to improve outcomes.
This study tests whether removing enlarged lymph nodes near the heart and lungs during surgery for advanced ovarian cancer can help you live longer and feel better. You must have already had surgery to remove most of your tumor and have specific lymph node changes on imaging.
Hear when a new Ovarian cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.